Many Uses, Much Controversy
Dimethyl sulfoxide (DMSO), a
by-product of the wood industry, has been in use as a commercial solvent since
1953. It is also one of the most studied but least understood pharmaceutical
agents of our time--at least in the United States. According to Stanley Jacob,
MD, a former head of the organ transplant program at Oregon Health Sciences
University in Portland, more than 40,000 articles on its chemistry have appeared
in scientific journals, which, in conjunction with thousands of laboratory
studies, provide strong evidence of a wide variety of properties. (See Major
Properties Attributed to DMSO) Worldwide, some 11,000 articles have been written
on its medical and clinical implications, and in 125 countries throughout the
world, including Canada, Great Britain, Germany, and Japan, doctors prescribe it
for a variety of ailments, including pain, inflammation, scleroderma,
interstitial cystitis, and arthritis elevated intercranial pressure.
Yet in the United States, DMSO has
Food and Drug Administration (FDA) approval only for use as a preservative of
organs for transplant and for interstitial cystitis, a bladder disease. It has
fallen out of the limelight and out of the mainstream of medical discourse,
leading some to believe that it was discredited. The truth is more complicated.
History of Controversy
The history of DMSO as a
pharmaceutical began in 1961, when Dr. Jacob was head of the organ transplant
program at Oregon Health Sciences University. It all started when he first
picked up a bottle of the colorless liquid. While investigating its potential as
a preservative for organs, he quickly discovered that it penetrated the skin
quickly and deeply without damaging it. He was intrigued. Thus began his
lifelong investigation of the drug.
The news media soon got word of his
discovery, and it was not long before reporters, the pharmaceutical industry,
and patients with a variety of medical complaints jumped on the news. Because it
was available for industrial uses, patients could dose themselves. This early
public interest interfered with the ability of Dr. Jacob--or, later, the FDA--to
see that experimentation and use were safe and controlled and may have
contributed to the souring of the mainstream medical community on it.
Why, if DMSO possesses half the
capabilities claimed by Dr. Jacob and others, is it still on the sidelines of
medicine in the United States today?
"It's a square peg being
pushed into a round hole," says Dr. Jacob. "It doesn't follow the
rifle approach of one agent against one disease entity. It's the aspirin of our
era. If aspirin were to come along today, it would have the same problem. If
someone gave you a little white pill and said take this and your headache will
go away, your body temperature will go down, it will help prevent strokes and
major heart problems--what would you think?"
Others cite DMSO's principal side
effect: an odd odor, akin to that of garlic, that emanates from the mouth
shortly after use, even if use is through the skin. Certainly, this odor has
made double-blinded studies difficult. Such studies are based on the premise
that no one, neither doctor nor patient, knows which patient receives the drug
and which the placebo, but this drug announces its presence within minutes.
Others, such as Terry Bristol, a
Ph.D. candidate from the University of London and president of the Institute for
Science, Engineering and Public Policy in Portland, Oregon, who assisted Dr.
Jacob with his research in the 1960s and 1970s, believe that the smell of DMSO
may also have put off the drug companies, that feared it would be hard to
market. Worse, however, for the pharmaceutical companies was the fact that no
company could acquire an exclusive patent for DMSO, a major consideration when
the clinical testing required to win FDA approval for a drug routinely runs into
millions of dollars. In addition, says Mr. Bristol, DMSO, with its wide range of
attributes, would compete with many drugs these companies already have on the
market or in development.
The FDA and
In the first flush of enthusiasm
over the drug, six pharmaceutical companies embarked on clinical studies. Then,
in November 1965, a woman in Ireland died of an allergic reaction after taking
DMSO and several other drugs. Although the precise cause of the woman's death
was never determined, the press reported it to be DMSO. Two months later, the
FDA closed down clinical trials in the United States, citing the woman's death
and changes in the lenses of certain laboratory animals that had been given
doses of the drug many times higher than would be given humans.
Some 20 years and hundreds of
laboratory and human studies later, no other deaths have been reported, nor have
changes in the eyes of humans been documented or claimed. Since then, however,
the FDA has refused seven applications to conduct clinical studies, and approved
only 1, for intersititial cystitis, which subsequently was approved for
prescriptive use in 1978.
Dr. Jacob believes the FDA
"blackballed" DMSO, actively trying to kill interest in a drug that
could end much suffering. Jack de la Torre, MD, Ph.D., professor of neurosurgery
and physiology at the University of New Mexico Medical School in Albuquerque, a
pioneer in the use of DMSO and closed head injury, says, "Years ago the FDA
had a sort of chip on its shoulder because it thought DMSO was some kind of
snake oil medicine. There were people there who were openly biased against the
compound even though they knew very little about it. With the new administration
at that agency, it has changed a bit." The FDA recently granted permission
to conduct clinical trials in Dr. de la Torre's field of closed head injury.
Penetrates Membranes and Eases Pain
The first quality that struck Dr.
Jacob about the drug was its ability to pass through membranes, an ability that
has been verified by numerous subsequent researchers.1 DMSO's ability to do this
varies proportionally with its strength--up to a 90 percent solution. From 70
percent to 90 percent has been found to be the most effective strength across
the skin, and, oddly, performance drops with concentrations higher than 90
percent. Lower concentrations are sufficient to cross other membranes. Thus, 15
percent DMSO will easily penetrate the bladder.2
In addition, DMSO can carry other
drugs with it across membranes. It is more successful ferrying some drugs, such
as morphine sulfate, penicillin, steroids, and cortisone, than others, such as
insulin. What it will carry depends on the molecular weight, shape, and
electrochemistry of the molecules. This property would enable DMSO to act as a
new drug delivery system that would lower the risk of infection occurring
whenever skin is penetrated.
DMSO perhaps has been used most
widely as a topical analgesic, in a 70 percent DMSO, 30 percent water solution.
Laboratory studies suggest that DMSO cuts pain by blocking peripheral nerve C
fibers.3 Several clinical trials have demonstrated its effectiveness,4,5
although in one trial, no benefit was found.6 Burns, cuts, and sprains have been
treated with DMSO. Relief is reported to be almost immediate, lasting up to 6
hours. A number of sports teams and Olympic athletes have used DMSO, although
some have since moved on to other treatment modalities. When administration
ceases, so do the effects of the drug.
Dr. Jacob said at a hearing of the
U.S. Senate Subcommittee on Health in 1980, "DMSO is one of the few agents
in which effectiveness can be demonstrated before the eyes of the
observers....If we have patients appear before the Committee with edematous
sprained ankles, the application of DMSO would be followed by objective
diminution of swelling within an hour. No other therapeutic modality will do
Chronic pain patients often have to
apply the substance for 6 weeks before a change occurs, but many report relief
to a degree they had not been able to obtain from any other source.
DMSO reduces inflammation by
several mechanisms. It is an antioxidant, a scavenger of the free radicals that
gather at the site of injury. This capability has been observed in experiments
with laboratory animals7 and in 150 ulcerative colitis patients in a
double-blinded randomized study in Baghdad, Iraq.8 DMSO also stabilizes
membranes and slows or stops leakage from injured cells.
At the Cleveland Clinic Foundation
in Cleveland, Ohio, in 1978, 213 patients with inflammatory genitourinary
disorders were studied. Researchers concluded that DMSO brought significant
relief to the majority of patients. They recommended the drug for all
inflammatory conditions not caused by infection or tumor in which symptoms were
severe or patients failed to respond to conventional therapy.9
Stephen Edelson, MD, F.A.A.F.P.,
F.A.A.E.M., who practices medicine at the Environmental and Preventive Health
Center of Atlanta, has used DMSO extensively for 4 years. "We use it
intravenously as well as locally," he says. "We use it for all sorts
of inflammatory conditions, from people with rheumatoid arthritis to people with
chronic low back inflammatory-type symptoms, silicon immune toxicity syndromes,
any kind of autoimmune process.
"DMSO is not a cure," he
continues. "It is a symptomatic approach used while you try to figure out
why the individual has the process going on. When patients come in with
rheumatoid arthritis, we put them on IV DMSO, maybe three times a week, while we
are evaluating the causes of the disease, and it is amazing how free they get.
It really is a dramatic treatment."
As for side effects, Dr. Edelson
says: "Occasionally, a patient will develop a headache from it, when used
intravenously--and it is dose related." He continues: "If you give a
large dose, [the patient] will get a headache. And we use large doses. I have
used as much as 30ÝmlÝIV over a couple of hours. The odor is a problem. Some
men have to move out of the room [shared] with their wives and into separate
bedrooms. That is basically the only problem."
DMSO was the first nonsteroidal
anti-inflammatory discovered since aspirin. Mr. Bristol believes that it was
that discovery that spurred pharmaceutical companies on to the development on
other varieties of nonsteroidal anti-inflammatories. "Pharmaceutical
companies were saying that if DMSO can do this, so can other compounds,"
says Mr. Bristol. "The shame is that DMSO is less toxic and has less int he
way of side effects than any of them."
Scleroderma is a rare, disabling,
and sometimes fatal disease, resulting form an abnormal buildup of collagen in
the body. The body swells, the skin--particularly on hands and face--becomes
dense and leathery, and calcium deposits in joints cause difficulty of movement.
Fatigue and difficulty in breathing may ensue. Amputation of affected digits may
be necessary. The cause of scleroderma is unknown, and, until DMSO arrived,
there was no known effective treatment.
Arthur Scherbel, MD, of the
department of rheumatic diseases and pathology at the Cleveland Clinic
Foundation, conducted a study using DMSO with 42 scleroderma patients who had
already exhausted all other possible therapies without relief. Dr. Scherbel and
his coworkers concluded 26 of the 42 showed good or excellent improvement.
Histotoxic changes were observed together with healing of ischemic ulcers on
fingertips, relief from pain and stiffness, and an increase in strength. The
investigators noted, "It should be emphasized that these have never been
observed with any other mode of therapy."10 Researchers in other studies
have since come to similar conclusions.11
Does DMSO Help
It was inevitable that DMSO, with
its pain-relieving, collagen-softening, and anti-inflammatory characteristics,
would be employed against arthritis, and its use has been linked to arthritis as
much as to any condition. Yet the FDA has never given approval for this
indication and has, in fact, turned down three Investigational New Drug (IND)
applications to conduct extensive clinical trials.
Moreover, its use for arthritis
remains controversial. Robert Bennett, MD, F.R.C.P., F.A.C.R., F.A.C.P.,
professor of medicine and chief, division of arthritis and rheumatic disease at
Oregon Health Sciences University (Dr. Jacob's university), says other drugs
work better. Dava Sobel and Arthur Klein conducted their own informal study of
47 arthritis patients using DMSO in preparation for writing their book,
Arthritis: What Works, and came to the same conclusion.12
Yet laboratory studies have
indicated that DMSO's capacity as a free-radical scavenger suggests an important
role for it in arthritis.13 The Committee of Clinical Drug Trials of the
Japanese Rheumatism Association conducted a trial with 318 patients at several
clinics using 90 percent DMSO and concluded that DMSO relieved joint pain and
increased range of joint motion and grip strength, although performing better in
more recent cases of the disease.14 It is employed widely in the former Soviet
Union for all the different types of arthritis, as it is in other countries
around the world.
Dr. Jacob remains convinced that it
can play a significant role in the treatment of arthritis. "You talk to
veterinarians associated with any race track, and you'll find there's hardly an
animal there that hasn't been treated with DMSO. No veterinarian is going to
give his patient something that does not work. There's no placebo effect on a
Central Nervous System Trauma
Since 1971, Dr. de la Torre, then
at the University of Chicago, has experimented using DMSO with injury to the
central nervous system. Working with laboratory animals, he discovered that DMSO
lowered intracranial pressure faster and more effectively than any other drug.
DMSO also stabilized blood pressure, improved respiration, and increased urine
output by five times and increased blood flow through the spinal cord to areas
of injury.15-17 Since then, DMSO has been employed with human patients suffering
severe head trauma, initially those whose intracranial pressure remained high
despite the administration of mannitol, steroids, and barbiturates. In humans,
as well as animals, it has proven the first drug to significantly lower
intracranial pressure, the number one problem with severe head trauma.
"We believe that DMSO may be a
very good product for stroke," says Dr. de la Torre, "and that is a
devastating illness which affects many more people than head injury. We have
done some preliminary clinical trials, and there's a lot of animal data showing
that it is a very good agent in dissolving clots."
Applications for DMSO
Many other uses for DMSO have been
hypothesized from its known qualities hand have been tested in the laboratory or
in small clinical trials. Mr. Bristol speaks with frustration about important
findings that have never been followed up on because of the difficulty in
finding funding and because "to have on your resume these days that you've
worked on DMSO is the kiss of death." It is simply too controversial. A
sampling of some other possible applications for this drug follows.
DMSO as long been used to promote
healing. People who have it on hand often use it for minor cuts and burns and
report that recovery is speedy. Several studies have documented DMSO use with
soft tissue damage, local tissue death, skin ulcers, and burns.18-21
In relation to cancer, several
properties of DMSO have gained attention. In one study with rats, DMSO was found
to delay the spread of one cancer and prolong survival rates with another.22 In
other studies, it has been found to protect noncancer cells while potentiating
the chemotherapeutic agent.
Much has been written recently
about the worldwide crisis in antibiotic resistance among bacteria (see
Alternative & Complementary Therapies, Volume 2, Number 3, 1996, pages
140-144) Here, too, DMSO may be able to play a role. Researcher as early as 1975
discovered that it could break down the resistance certain bacteria have
In addition to its ability to lower
intracranial pressure following closed head injury, Dr. de la Torre's work
suggests that the drug may actually have the ability to prevent paralysis, given
its ability to speedily clean out cellular debris and stop the inflammation that
prevents blood from reaching muscle, leading to the death of muscle tissue.
With its great antioxidant powers,
DMSO could be used to mitigate some of the effects of aging, but little work has
been done to investigate this possibility. Toxic shock, radiation sickness, and
septicemia have all been postulated as responsive to DMSO, as have other
conditions too numerous to mention here.
DMSO in the
Will DMSO ever sit on the shelves
of pharmacies in this country as a legal prescriptive for many of the conditions
it may be able to address? Will the studies we need to discover when this drug
is most appropriate ever be done? Given the difficulties the drug has run into
so far and the recent development of new drugs that perform some of the same
functions, Mr. Bristol is doubtful. Others, however, such as Dr. Jacob and Dr.
de la Torre, see the FDA approval of DMSO for interstitial cystitis and the more
recent FDA go-ahead for DMSO trials with closed head injury as new indications
of hope. The cystitis approval means that physicians may use it at their
discretion for other uses, giving DMSO a new legitimacy.
Dr. Jacob continues to believe that
DMSO should not even be called a drug but is more correctly a new therapeutic
principle, with an effect on medicine that will be profound in many areas.
Whether that is true cannot be known without extensive a publicly reported
trials, which are dependent on the willingness of researchers to undertake
rigorous studies in this still-unfashionable tack and of pharmaceutical
companies and other investors to back them up. That this is a live issue is
proved by the difficulty the investigators with approval to test DMSO for closed
head injury clinically are having finding funds to conduct the trials.
In 1980, testifying before the
Select Committee on Agin of the U.S. House of Representatives, Dr. Scherbel
said, "The controversy that exists over the clinical effectiveness of DMSO
is not well-founded--clinical effectiveness may be variable in different
patients. If toxicity is consistently minimal, the drug should not be restricted
from practice. The clinical effectiveness of DMSO can be decided with complete
satisfaction if the drug is made available to the practicing physician. The
number of patient complaints about pain and the number of phone calls to the
doctor's office will decide quickly whether or not the drug is effective."
It may be premature to call for the
full rehabilitation of DMSO, but it is time to call for a full investigation of
its true range of capabilities.
- Kolb, K.H., Jaenicke, G., Kramer, M., Schulze, P.E. Absorption,
distribution, and elimination of labeled dimethyl sulfoxide in man and
animals. Ann NY Acad Sci 141:85-95, 1967.
- Herschler, R., Jacob, S.W. The case of dimethyl sulfoxide. In: Lasagna, L.
(Ed.), Controversies in Therapeutics. Philadelphia: W.B. Saunders,
- Evans, M.S., Reid, K.H., Sharp, J.B. Dimethyl sulfoxide (DMSO) blocks
conduction in peripheral nerve C fibers: A possible mechanism of analgesia. Neurosci
Lett 150:145-148, 1993.
- Demos, C.H., Beckloff, G.L., Donin, M.N., Oliver, P.M. Dimethyl sulfoxide
in musculoskeletal disorders. Ann NY Acad Sci 141:517-523, 1967.
- Lockie, L.M., Norcross, B. A clinical study on the effects of dimethyl
sulfoxide in 103 patients with acute and chronic musculoskeletal injures and
inflammation. Ann NY Acad Sci 141:599-602, 1967.
- Percy, E.C., Carson, J.D. The use of DMSO in tennis elbow and rotator cuff
tendinitis: A double-blind study. Med Sci Sports Exercise
- Itoh, M., Guth, P. Role of oxygen-derived free radicals in hemorrhagic
shock-induced gastric lesions in the rat. Gastroenterology
- Salim, A.S., Role of oxygen-derived free radical scavengers in the
management of recurrent attacks of ulcerative colitis: A new approach. J.
Lab Clin Med 119:740-747, 1992.
- Shirley, S.W., Stewart, B.H., Mirelman, S. Dimethyl sulfoxide in treatment
of inflammatory genitourinary disorders. Urology 11:215-220, 1978.
- Scherbel, A.L., McCormack, L.J., Layle, J.K. Further observations on the
effect of dimethyl sulfoxide in patients with generalized scleroderma
(progressive systemic sclerosis). Ann NY Acad Sci 141:613-629,
- Engel, M.F., Dimethyl sulfoxide in the treatment of scleroderma. South
Med J 65:71, 1972.
- Sobel, D., Klein, A.C. Arthritis: What Works. New York: St.
Martins Press, 1989.
- Santos, L., Tipping, P.G. Attenuation of adjuvant arthritis in rats by
treatment with oxygen radical scavengers. Immunol Cell Biol
- Matsumoto, J. Clinical trials of dimethyl sulfoxide in rheumatoid
arthritis patients in Japan. Ann NY Acad Sci 141:560-568, 1967.
- de la Torre, J.C., et al. Modifications of experimental spinal cord
injuries using dimethyl sulfoxide. Trans Am Neurol Assoc 97:230,
- de la Torre, J.C., et al. Dimethyl sulfoxide in the treatment of
experimental brain compression. J Neurosurg 38:343, 1972.
- de la Torre, J.C., et al. Dimethyl sulfoxide in the central nervous system
trauma. Ann NY Acad Sci 243:362, 1975.
- Lawrence, H.H., Goodnight, S.H. Dimethyl sulfoxide and extravasion of
anthracycline agents. Ann Inter Med 98:1025, 1983.
- Lubredo, L., Barrie, M.S., Woltering, E.A. DMSO protects against
adriamycin-induced skin necrosis. J. Surg Res 53:62-65, 1992.
- Alberts, D.S., Dorr, R.T. Case report: Topical DMSO for
mitomycin-C-induced skin ulceration. Oncol Nurs Forum 18:693-695,
- Cruse, C.W., Daniels, S. Minor burns: Treatment using a new drug deliver
system with silver sulfadiazine. South Med J 82:1135-1137, 1989.
- Miller, L., Hansbrough, J., Slater, H., et al. Sildimac: A new deliver
system for silver sulfadiazine in the treatment of full-thickness burn
injuries. J Burn Care Rehab 11:35-41, 1990
- Salim, A. Removing oxygen-derived free radicals delays hepatic metastases
and prolongs survival in colonic cancer. Oncology 49:58-62, 1992.
- Feldman, W.E., Punch, J.D.,
Holden, P. In vivo and in vitro effects of dimethyl sulfoxide on
streptomycin-sensitive and resistant Escherichia coli. Ann Acad
Sci 141:231, 1967.
Source: Alternative &
Complementary Therapies, July/August 1996, pages 230-235. DMSO Organization
would like to thank the publisher for permission to place this fine article on
the World Wide Web. The Publisher retains all copyright. To order reprints of
this article, write to or call: Karen Ballen, Alternative & Complementary
Therapies, Mary Ann Liebert, Inc., 2 Madison Avenue, Larchmont, NY 10538, (914)
Dave Mihalovic, Prevent
Use of DMSO (Dimethyl sulfoxide) in medicine dates back decades. It was
predominantly used as a topical anagesic, anti-inflammatory and antioxidant.
Today, we know that DMSO can treat a variety of disorders including arthritis,
mental illness, emphysema, and even cancer. While this is now
considered a superb cancer treatment, orthodox medicine is not interested in
discussing its benefits. If DMSO were to be implemented and used in cancer
treatment, the “true cure rate” for orthodox medicine would rise from 3% to
above 90%! Here’s why.
Supporters of DMSO have long supported the claim that it can cause cancerous
cells to become noncancerous, or benign, and can slow or stop the progress of
cancer in the bladder, colon, ovary, breast, and skin. Some evidence even
suggest it is useful in treating leukemia, and it has also been used as a part
of some metabolic cancer therapies.
DMSO was first discovered in the mid- to late nineteenth century. In the
1950s, it was discovered that DMSO could protect cells from the damage of
freezing. In the 1960s, Dr. Stanley Jacob, one of the main proponents of DMSO,
began to study other medicinal properties of the substance. In the 1970s, DMSO
was approved for use as an anti-inflammatory treatment in dogs and horses and as
a prescription drug for a type of bladder inflammation in humans.
If orthodox medicine were truly interested in curing cancer, don’t you
think they would look for a way to target cancer cells with the intent of
killing them while sparing normal cells?
Chemotherapy does not target cancer cells, and because of this, chemotherapy:
1) Kills far more normal cells than cancer cells, and
2) Damages and toxifies many of the normal cells that do survive.
If a “magic bullet” were used FIRST by
orthodox medicine, meaning thecut/burn/slash/poison
treatments were avoided, a 90% true cure rate would be easy to achieve. But
the fact of the matter is that the leaders in the medical community have
absolutely no interest in finding a “magic bullet.” A “magic bullet”
would cost the drug companies hundreds of billions of dollars, patients would
have less hospitalization, less doctor visits, etc. The fact is, no
one wants a “magic bullet” to be found. The evidence that this
is true is that two “magic bullets” are already known to exist, but no one
is using them except for a handful of doctors.
What Causes Cancer?
Most people believe that it is DNA damage that causes cancer. While in rare
situations, DNA can have a negative affect on a person’s immune system, DNA
normally has absolutely nothing to do with the development of cancer.
The fact is that cancer is caused by a special type of microbe which gets
inside of normal cells and turns the cells cancerous.
Cancer is an invading disease that attacks the body’s immune system. Once
detected, cancer has already had enough time to establish its web network.
Treating the tumor is not good enough–it is only the start.
Actually, everyone has cancer cells forming in their body at all times. The
immune system generally safely kills them. However, this means that a weakened
immune system, and many other things, can allow cancer cells to overcome the
immune system. But the actual formation of cancer cells is exclusively caused by
microbes which get inside of normal cells.
Dr. Royal Rife did an enormous amount of research into the relationship
between microbes and cancer in the 1930s. He would inject mice with a virus and
in 100% of the cases the mice would get cancer.
Dr. Rife proposed a cure for cancer which did nothing but kill the
viruses/microbes which were inside of the cancer
cells. His cure was 100% successful. However, note that his cure
had no intention of killing cancer cells or fixing DNA (which had not been
discovered in the 1930s); its only goal was to kill microbes which were both
inside and outside of the cancer cells. Once the microbes were
dead the cancer cells were able to revert back into normal, differentiated
Dr. Rife was well aware that the critial microbes which needed to be killed
were inside the cancer cells. The electromedicine device he used killed microbes
inside and outside of cancer cells.
But almost all natural substances do not normally get inside of cells, thus
it is almost impossible for natural substances to kill the microbes inside the
cancer cells. Natural substances can kill cancer cells and build the immune
system, but they generally cannot kill microbes inside the cancer cells.
There is no single cure for treating cancer; cancer must be approached and
treated holistically. The cellular process in developing cancer takes many
years–with the exception of high radiation or other toxic exposure, a
compromised immunity and cell damage does not happen overnight. Treatment must
be approached defensively and directly; focus on the cause and do not treat
cancer in reverse. Target your treatment mentally and physically from the very
You might ask your oncologist why your chances of survival are only 3%
(ignoring all of their statistical gibberish such as “5-year survival rates”
and deceptive terms like “remission” and “response”), when your chance
of survival would be over 90% if they used DMSO.
It would be better for medical doctors to treat cancer patients with
the right treatment than to have patients treat themselves at
home. Medical doctors can diagnose better, treat better, watch for developing
problems better, etc. Unfortunately, doctors are using treatments that have been
chosen solely on the basis of their profitability rather than their
DMSO is a highly non-toxic, 100% natural product that comes from the wood
industry. But of course, like so many other potential cancer cures, the
discovery was buried. DMSO, being a natural product, cannot be patented and
cannot be made profitable because it is produced by the tonin
the wood industry. The only side-effect of using DMSO in humans is body odor
(which varies from patient to patient).
The FDA took note of the effectiveness of DMSO at treating pain and made it
illegal for medical uses in order to protect the profits of the aspirin
companies (in those days aspirin was used to treat arthritis). Thus, it must be
sold today as a “solvent.” Few people can grasp the concept that government
agencies are organized for the sole purpose of being the “police force” of
large, corrupt corporations.
While it is generally believed that orthodox medicine and modern corrupt
politicians persecute alternative medicine, this is not technically correct.
What they do is persecute ANY cure for cancer, it
doesn’t matter whether it is orthodox or alternative. The proof of this is
DMSO. It appears that orthodox medicine persecutes alternative medicine only
because there are far more alternative cancer treatments that can cure cancer
than orthodox treatments.
Another substance that targets cancer cells is being researched at Purdue
University and other places: folic acid. This too will be buried unless it can
lead to more profitable cancer treatments.
But alternative medicine is rightfully not interested in combining DMSO with
chemotherapy. DMSO will combine with many substances, grab them, and drag them
into cancer cells. It will also blast through the blood-brain barrier like it
wasn’t even there.
DMSO has been combined successfully with hydrogen peroxide (e.g. see
Donsbach), cesium chloride, MSM (though it may not bind to MSM), and other
DMSO – Vitamin C Treatment
Vitamin C is so simlar to glucose, that cells, and especially cancer cells,
consume vitamin C the same way they would consume glucose.
Cancer cells are anaerobic obligates, which means they depend upon glucose as
their primary source of metabolic fuel. Cancer cells employ transport mechanisms
called glucose transporters to actively pull in glucose.
In the vast majority of animals, vitamin C is synthesized from glucose in
only four metabolic steps. Hence, the molecular shape of vitamin C is remarkably
similar to glucose. Cancer cells will actively transport vitamin C into
themselves, possibly because they mistake it for glucose. Another plausible
explanation is that they are using the vitamin C as an antioxidant. Regardless,
the vitamin C accumulates in cancer cells.
If large amounts of vitamin C are presented to cancer cells, large amounts
will be absorbed. In these unusually large concentrations, the antioxidant
vitamin C will start behaving as a pro-oxidant as it interacts with
intracellular copper and iron. This chemical interaction produces small amounts
of hydrogen peroxide.
Because cancer cells are relatively low in an intracellular anti-oxidant
enzyme called catalase, the high dose vitamin C induction of peroxide will
continue to build up until it eventually lyses the cancer cell from the inside
out! This effectively makes high dose IVC a non-toxic chemotherapeutic agent
that can be given in conjunction with conventional cancer treatments. Based on
the work of several vitamin C pioneers before him, Dr. Riordan was able to prove
that vitamin C was selectively toxic to cancer cells if given intravenously.
This research was recently reproduced and published by Dr. Mark Levine at the
National Institutes of Health.
As feared by many oncologists, small doses may actually help the cancer cells
because small amounts of vitamin C may help the cancer cells arm themselves
against the free-radical induced damage caused by chemotherapy and radiation.
Only markedly higher doses of vitamin C willselectively build
up as peroxide in the cancer cells to the point of acting in a manner similar to
chemotherapy. These tumor-toxic dosages can only be obtained by intravenous
Over a span of 15 years of vitamin C research, Dr. Riordan’s RECNAC (cancer
spelled backwards) research team generated 20 published papers on vitamin C and
cancer. RECNAC even inspired its second cancer research institute, known as
RECNAC II, at the University of Puerto Rico. This group recently published an
excellent paper in Integrative Cancer Therapies, titled
“Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later.”
RECNAC data has shown that vitamin C is toxic to tumor cells without sacrificing
the performance of chemotherapy.
Intravenous vitamin C also does more than just kill cancer cells. It boosts
immunity. It can stimulate collagen formation to help the body wall off the
tumor. It inhibits hyaluronidase, an enzyme that tumors use to metastasize and
invade other organs throughout the body. It induces apoptosis to help program
cancer cells into dying early. It corrects the almost universal scurvy in cancer
patients. Cancer patients are tired, listless, bruise easily, and have a poor
appetite. They don’t sleep well and have a low threshold for pain. This adds
up to a very classic picture of scurvy that generally goes unrecognized by their
Because cancer cells consume 15 times more glucose than normal cells, under
the right conditions, cancer cells should consume 15 times more vitamin C than a
normal cell. While normal cells benefit from vitamin C, the microbes inside of
the cancer cells may be killed by vitamin C. It is microbes which are inside of
the cancer cells which cause cancer and which force a cancer cell to remain
It should be mentioned that two-time Nobel Prize winner Linus Pauling, and an
associate, Dr. Ewan Cameron, M.D., were able to extend the lives of cancer
patients more than 10-fold using only 10
grams of vitamin C a day by I.V.
Why Selling Natural Products is Such a Dangerous Business To legally market a drug (that is, any substance that can claim to cure, prevent, mitigate, or treat a disease), it must go through the lengthy and expensive FDA drug approval process. Any violation - that is, any sale of a "drug" that is not FDA-approved - can lead to seizure of the product, injunctions against its sale and distribution, and criminal penalties, including imprisonment, for the manufacturer.
Soursop Fruit 100 Fold Stronger At Killing Cancer Than Chemotherapy. Besides being a cancer remedy, graviola is a broad spectrum antimicrobial agent for both bacterial and fungal infections, is effective against internal parasites and worms, lowers high blood pressure and is used for depression, stress and nervous disorders.
The Health Benefits of Cloves. The active principles in the clove are known to have antioxidant, anti-septic, local anesthetic, anti-inflammatory, rubefacient (warming and soothing), carminative and anti-flatulent properties.
Comfrey. Healing for wounds, and helpful in high blood pressure, diabetes, and more.
Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood. Cardamonin acts upon major pro-inflammatory mediators.
Chelerythrine. Chelerythrine is a benzophenanthridine alkaloid extracted from the plant Greater celandine (Chelidonium majus) and from Blood Root (Sanguinaria canadensis). It is a potent, selective, and cell-permeable protein kinase C inhibitor (may improve mood and benefit the heart, is used in several anti-cancer drugs).
What is Nigella Sativa? (Jintan Hitam). Black seed is used for treating gastrointestinal conditions including gas, colic, diarrhea, dysentery, constipation and haemorrhoids. It is also used for respiratory conditions, including asthma, allergies, cough, bronchitis, emphysema, flu and congestion. Additionally, it is used as an antihypertensive, immunoprotectant, anticancer agent, and vermifuge.
About BSI Mangiferin. The colorful history of Mangiferin dates more than 1000 years, a mainstay of Chinese medicine, Balean medicine in Indonesia, and ethno-medicine in Cuba.
Keladi tikus / Typhonium flagelliforme (Lodd.) Bl. The type of cancer that can be inhibited by rodent tuber is in addition to breast cancer nasopharyngeal cancer, liver, cancer of the cervix, pancreas, prostate, lung and many more. In addition to cancer, according to some studies also mentioned that taro rats can be used for people who have drug addiction.
Noni Fruit and Juice and its Benefits. Noni mimics the secretion coming from the pineal gland, and in fact acts as a precursor to it, building it up and allowing it to function fully. It is a noted analgesic or pain reliever.
California Poppy. The California poppy contains protopine, which has similar (but much milder effects) as morphine, making it a good natural sedative.
Research: Pineapple Bromelain Enzyme Kills Cancer Without Killing You. How then, can something as innocuous as the enzyme from the stem/core of a pineapple be superior to a drug that millions of cancers patients over the past 40 years have placed their hopes of recovery on, as well as exchanging billions of dollars for?
Health Benefits of Aloe Vera. Not only does it contain vitamin B12 but several other minerals that are important for the health of our bodies. Aloe vera also contains calcium, protein, zinc, magnesium, vitamins A, and E, germanium, essential fatty acids and amino acids.
The Magic Duo for Cancer Treatment That Frightens The FDA and Conventional Medicine: DMSO.Dimethyl sulfoxide (DMSO), a by-product of the wood industry, has been in use as a commercial solvent since 1953. DMSO can carry other drugs with it across membranes. It is more successful ferrying some drugs, such as morphine sulfate, penicillin, steroids, and cortisone, than others, such as insulin. What it will carry depends on the molecular weight, shape, and electrochemistry of the molecules. This property would enable DMSO to act as a new drug delivery system that would lower the risk of infection occurring whenever skin is penetrated.
6 Benefits of Papaya Leaves to the Human Body One supplement you should not overlook is Papaya Leaf Extract. Papayas are excellent sources of dietary fiber, vitamin C, vitamin A, vitamin E, and folate, while at the same time being rich in antioxidants, flavonoids, and carotenes. Papayas also contain high amounts of enzymes called papain and chymopapain, which are critical ingredients for a healthy body.
Health Benefits of Pine Essential Oil. The health benefits of pine essential oil include its ability to reduce inflammation and associated redness, protect against sinus infections, clear mucus and phlegm, cure skin conditions like eczema and psoriasis, boost the immune system, fight fungal and viral infections, stimulate the mind and body, and protecting your home and body from a wide variety of germs.
Gelatin Capsules Sizes and shapes of Gelatin Capsules.
All About Zinc. Zinc is an essential element, necessary for sustaining all life. It is estimated that 3000 of the hundreds of thousands of proteins in the human body contain zinc. Signs of zinc deficiency includes hair loss, skin lesions, diarrhea, wasting of body tissues. Prolonged lack of zinc can result in death.
Master Index of Health-Related Articles on BSI.International